Ibraheem Bashar, Wagner Karl G
Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany.
Int J Pharm X. 2021 Mar 18;3:100075. doi: 10.1016/j.ijpx.2021.100075. eCollection 2021 Dec.
Enabling formulations often depend on functional excipients. However, the question remains whether excipients regarded as standard establish similar interactions and subsequently improvement of solubility when employed at unusual manufacturing process conditions. In this study, compaction of API under high pressure in the presence of hydrophilic excipients is proposed as a technique to improve the solubility and/or dissolution rate with an acceptable preservation of the supersaturation state. Binary mixtures of ibuprofen (IBU) with hydroxypropyl cellulose, isomalt, mannitol and sorbitol were compacted applying high pressure (500 MPa) with and without a previous co-milling step. Intrinsic dissolution rate (IDR) was selected to characterize and evaluate dissolution performance. The IDR of neat IBU increased from 5 to 88 fold and the aqueous solubility in the range of 3 to 54%. Regarding the polyols isomalt showed the highest impact on solubility and dissolution, without changing the crystallinity of IBU independent of a co-milling step. Even higher impact was achieved in combination with HPC. However, only without a previous co-milling step, ibuprofen remained crystalline, while co-milling induced an amorphous IBU-content of 38%. Based on XRPD and DSC findings, higher IDR and solubility values correlated with crystal modifications as well as IBU/excipient interactions.
赋形剂通常依赖于功能性辅料。然而,问题仍然存在,即被视为标准的辅料在不寻常的制造工艺条件下使用时是否会建立相似的相互作用并随后改善溶解度。在本研究中,提出在亲水性辅料存在下对原料药进行高压压片,作为一种在可接受的过饱和状态保持下提高溶解度和/或溶解速率的技术。布洛芬(IBU)与羟丙基纤维素、异麦芽酮糖醇、甘露醇和山梨醇的二元混合物在有和没有预先共研磨步骤的情况下进行高压(500MPa)压片。选择固有溶解速率(IDR)来表征和评估溶解性能。纯IBU的IDR提高了5至88倍,水溶性提高了3%至54%。关于多元醇,异麦芽酮糖醇对溶解度和溶解的影响最大,无论是否有共研磨步骤,均不改变IBU的结晶度。与羟丙基纤维素联合使用时影响更大。然而,只有在没有预先共研磨步骤的情况下,布洛芬仍为结晶态,而共研磨导致无定形IBU含量为38%。基于X射线粉末衍射(XRPD)和差示扫描量热法(DSC)的结果,较高的IDR和溶解度值与晶体改性以及IBU/辅料相互作用相关。